NEW YORK (Reuters Health) Jun 13 – Reducing elevated intraocular pressure with topical hypotensive medication can prevent or delay the onset of primary open-angle glaucoma,
HULL, QC — June 19, 2002 — There may be cortical involvement in glaucoma which can be measured functionally through depth perception, researchers suggest. “There
SANTA CRUZ, CA — The same technology that astronomers are using to sharpen the images from ground-based telescopes is also giving eye specialists better techniques
HULL, QC — June 19, 2002 — Certain pre-operative conditions should be noted by surgeons to minimize complications associated with cataract surgeries, according to a
HULL, QC — June 17, 2002 — Current treatments for amblyopia are beneficial and likely are curbing the rate of monocular visual loss, researchers report.
HULL, QC — June 16, 2002 — Using topical and intracameral anesthesia is an alternative type of anesthesia that can be applied when performing penetrating
BETHESDA, MD — June 14, 2002 — Researchers have discovered that eye drops used to treat elevated pressure inside the eye can be effective in
NEW YORK (Reuters Health) Jun 13 – Reducing elevated intraocular pressure with topical hypotensive medication can prevent or delay the onset of primary open-angle glaucoma,
NEW YORK (Reuters Health) Jun 11 – Reconstruction following the removal of large ocular surface neoplasias (OSN) can be successfully accomplished with the use of
Swedish investigators have found a relationship between platelet aggregation inhibitors and optic disc hemorrhages that may indicate an association between such hemorrhages and generalized vascular
June 12, 2002 Helicobacter pylori infection has previously been linked to chronic open-angle glaucoma, and results of a study reported in the June 10
06/10/2002 By Mark Moran Swedish investigators have found a relationship between platelet aggregation inhibitors and optic disc hemorrhages that may indicate an association between such
06/04/2002By Mark Moran Transplantation of non-preserved human amniotic membrane may be an alternative for management of painful bullous keratopathy in patients with poor visual attention. The procedure
QLT Inc. and Novartis Ophthalmics, the eye health unit of Novartis AG, today announced that the Committee for Proprietary Medicinal Products (CPMP) of the European
NEW YORK (Reuters Health) May 16 – Without the use of a knife, sclerostomy by enzymatic treatment reduced intraocular pressure and relieved symptoms in patients
Retinal arteriolar narrowing is independently associated with increased risk of developing diabetes in middle-age patients. This association is seen even among people at low risk
NEW YORK (Reuters Health) May 24 – Sleep apnea may play an important pathogenic role in some patients with nonarteritic anterior ischemic optic neuropathy (NAION),
NEW YORK (Reuters Health) May 28 – Topical mitomycin C appears to be a safe and effective treatment for conjunctival or corneal squamous cell carcinoma
ORT LAUDERDALE, FL — May 8, 2002 — Switching to Xalatan® (latanoprost ophthalmic solution) once daily from monotherapy with other medications, including prostaglandin derivatives, for
FORT LAUDERDALE, FL — May 8, 2002 — Xalacom® (fixed combination latanoprost 0.005% and timolol 0.5%) once-daily is more effective for the reduction of intraocular